Trudhesa Spray, Metered
Product Images NDC 77530-725

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Trudhesa (NDC 77530-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Impel Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Trudhesa 01)

Chemical Structure (Trudhesa 01)
FDA Label Image

Figure 1 (Trudhesa 02)

Figure 1 (Trudhesa 02)
FDA Label Image

Figure 2 (Trudhesa 03)

Figure 2 (Trudhesa 03)
This is a table showing the estimated probability of response to study medication in percentage for studies 3 and 4 with 97 participants receiving Dihydroergotamine Mesylate and 100 receiving Placebo. The time from the first dose is not available.*
FDA Label Image

Figure 3 (Trudhesa 04)

Figure 3 (Trudhesa 04)
FDA Label Image

Image (Trudhesa 05)

Image (Trudhesa 05)
FDA Label Image

Figure (Trudhesa 06)

Figure (Trudhesa 06)
FDA Label Image

Figure (Trudhesa 07)

Figure (Trudhesa 07)
The text appears to be a jumbled combination of letters, symbols, and numbers, making it not available.*
FDA Label Image

Figure (Trudhesa 08)

Figure (Trudhesa 08)
FDA Label Image

Figure A (Trudhesa 09)

Figure A (Trudhesa 09)
FDA Label Image

Figure B (Trudhesa 10)

Figure B (Trudhesa 10)
FDA Label Image

Figure C (Trudhesa 11)

Figure C (Trudhesa 11)
FDA Label Image

Figure D (Trudhesa 12)

Figure D (Trudhesa 12)
FDA Label Image

Figure E (Trudhesa 13)

Figure E (Trudhesa 13)
FDA Label Image

Figure F (Trudhesa 14)

Figure F (Trudhesa 14)
FDA Label Image

Figure G (Trudhesa 15)

Figure G (Trudhesa 15)
FDA Label Image

Figure H (Trudhesa 16)

Figure H (Trudhesa 16)
FDA Label Image

Figure I (Trudhesa 17)

Figure I (Trudhesa 17)
FDA Label Image

Figure J (Trudhesa 18)

Figure J (Trudhesa 18)
FDA Label Image

Figure K (Trudhesa 19)

Figure K (Trudhesa 19)
This text provides instructions on how to properly prime a nasal spray device by pumping it exactly four times. It also instructs the user to press and then release the device.*
FDA Label Image

Figure L (Trudhesa 20)

Figure L (Trudhesa 20)
FDA Label Image

Figure M (Trudhesa 21)

Figure M (Trudhesa 21)
FDA Label Image

Figure N (Trudhesa 22)

Figure N (Trudhesa 22)
FDA Label Image

Figure O (Trudhesa 23)

Figure O (Trudhesa 23)
FDA Label Image

Principal Display Panel (0.725 mg Vial Carton)

Principal Display Panel (0.725 mg Vial Carton)
Trudhesa is a medication used for treating migraines without aura. It contains dihydroergotamine mesylate which helps in treating headaches. The medication is available in the form of nasal spray devices and Trudhesa vials that come with instructions for use and prescribing information. The recommended dosage should be followed as per the instructions mentioned in the prescribing information. The medication should be kept at room temperature and should not be refrigerated or frozen. The contents of the nasal spray devices are disposable and should be discarded after use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.